Jean Combalbert
Independent Chair
Jean has an impressive track record with over 25 years’ experience building research and development-stage biotech companies and achieving high-value exits.
Jean is currently a non-executive director at Epics Therapeutics SA, having previously served as its founding CEO from 2017. Jean was Chair of the Board at Syndesi Therapeutics SA from 2018 until its sale to AbbVie in 2022. Previously, he was CEO of Ogeda SA from 2006 until its sale to Astellas Pharma Inc. in 2017. Earlier in his career, Dr Combalbert held senior positions with Sanofi and Galderma in France and the United States. Jean hold a PharmD and PhD from University of Pharmacy, Marseille, France.